Company intelligence / Profile preview

Mikroliz

Ankara, Ankara, Turkeymikroliz.com ↗
Ownership
Private
Development stage
Other
01

Overview

Mikroliz is a Turkish biotechnology company specializing in the development of bacteriophage-based solutions to combat the global threat of antimicrobial resistance. Based in the Hacettepe University Technopolis, the company focuses on the isolation, characterization, and formulation of phages for applications in human health, veterinary medicine, and food safety. Mikroliz maintains an extensive phage bank and utilizes genomic sequencing to ensure the safety and efficacy of its therapeutic candidates. Their product pipeline includes phage cocktails designed to target multi-drug resistant pathogens and diagnostic tools for rapid bacterial identification. By providing precision-targeted alternatives to traditional antibiotics, Mikroliz aims to address critical unmet needs in infectious disease management and biocontrol.

Therapeutic areas
Infectious DiseasesWomen's Health
Modalities
Bacteriophage therapyMicrobial therapy
Industry
Biotech
02

Drug pipeline

1 asset

Achromobacter spp. bacteriophage 2001248D

Preclinical
03

Partnerships

Hacettepe UniversityHitit University

Beyond the preview

Go deeper on Mikroliz.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mikroliz.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call